Merck & Co. Inc.-0.03% $250.86B ...

Inovio Pharmaceuticals Inc. closed $12.82 below its 52-week high ($14.75), which the company achieved on April 1st.

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more here.

Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...

The company priced a public offering of 10 million shares of common stock and accompanying warrants. Inovio Pharmaceuticals Inc INO shares are trading lower by 40% to $2.23 during Friday’s ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Stephens has recently initiated Inovio Pharmaceuticals Inc (INO) stock to Overweight rating, as announced on May 14, 2024, according to Finviz. Earlier, on January 25, 2024, Oppenheimer had raised the ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...

State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...